The Teal Wand, an at-home HPV testing device that could replace a Pap smear, could broaden access to cervical cancer screening.

The FDA has approved an at-home, self-administered test for cervical cancer that's less invasive than a traditional pap smear ...

The FDA has granted approval to Teal Health's at-home cervical cancer screening wand, the first self-collection tool for HPV screening in the U.S. Kara Egan, the cofounder and CEO of Teal Health, ...

PRGN-2012 has the potential to be the first- and best-in-class treatment for RRP <li /> Company's BLA for PRGN-2012 for the treatment of ...

The KEYNOTE-B96 study of pembrolizumab plus paclitaxel in recurrent platinum-resistant ovarian cancer has met its primary end ...

President Trump was welcomed in Qatar by the emir, as the two leaders exchanged praises and discussed a sweeping economic agreement. The White House claimed the president signed a $1.2 trillion trade ...

Precision Oncology market is set for strong growth through 2035, fueled by genomic advances, rising cancer cases, and increased use of targeted therapies.

You will be redirected to our submission process. Cancer drug resistance poses a significant challenge in oncology, undermining the efficacy of chemotherapy, targeted therapy, and immunotherapy.